Effect of cell differentiation for neuroblastoma by vitamin K analogs

Japanese Journal of Clinical Oncology

Volumn 39, Issue 4, 2009, Pages 251-259

  Nakayama, Toshimitsu ^a   Asami, Satoru ^a   Ono, Shin Ichi ^a   Miura, Motofumi ^a   Hayasaka, Masatoshi ^a   Yoshida, Yoshikazu ^a   Toriyama, Masaharu ^a   Motohashi, Shigeyasu ^a   Suzuki, Takashi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Differentiation; Neuroblastoma; PTPase; TrkA; Vitamin K3

Indexed keywords

2 [(2 HYDROXY)ETHYLTHIO] 3 METHYL 1,4 NAPHTHOQUINONE; 2 [(2 METHOXY)ETHYLTHIO] 3 METHYL 1,4 NAPHTHOQUINONE; 2 [(2 METHOXYMETHOXY)ETHYLTHIO] 3 METHYL 1,4 NAPHTHOQUINONE; 2 [(2,3 DIHYDROXY)PROPYLTHIO] 3 METHYL 1,4 NAPHTHOQUINONE; 2 [2 (TETRAHYDRO 2H PYRAN 2 YLOXY)ETHYLTHIO] 3 METHYL 1,4 NAPHTHOQUINONE; 3 (1,4 DIHYDRO 3 METHYL 1,4 DIOXO 2 NAPHTHYLTHIO)PROPANOIC ACID; 3 METHYL 2[(2,2 DIMETHYL 1,3 DIOXOLAN 4 YL)METHYLTHIO] 1,4 NAPHTHOQUINONE; MENADIONE; MESSENGER RNA; NERVE GROWTH FACTOR RECEPTOR; NEUROMODULIN; PHYTOMENADIONE; PROTEIN C FOS; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; TYROSINE; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ARTICLE; AUTOPHOSPHORYLATION; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA; NEUROBLASTOMA CELL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; NEURITES; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; VITAMIN K 3;

EID: 63849189855     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp011     Document Type: Article

References (18)

1. Pierotti MA, Greco A. Oncogenic rearrangements of the NTRK1/NGF receptor. Cancer Lett 2006;232:90-8.
2. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 1993;85:377-84.
3. Borrello MG, Bongarzone I, Pierotti MA, Luksch R, Gasparini M, Collini P, et al. trk and ret proto-oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non-advanced stages. Int J Cancer 1993;54:540-5.
4. Chou AH, Zheng S, Itsukaichi T, Howard BD. Wnt-1 inhibits nerve growth factor-induced differentiation of PC12 cells by preventing the induction of some but not all late-response genes. Brain Res Mol Brain Res 2000;77:232-45.
5. Bolande RP. The neurocristopathies: A unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 1974;5: 409-29.
6. Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Oncologist 2003;8:278-92.
7. Ni R, Nishikawa Y, Carr BI. Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation. J Biol Chem 1998;273:9906-11.
8. Nishikawa Y, Wang Z, Kerns J, Wilcox CS, Carr BI. Inhibition of hepatoma cell growth in vitro by arylating and non-arylating K vitamin analogs. Significance of protein tyrosine phosphatase inhibition. J Biol Chem 1999;274:34803-10.
9. Wang Z, Ge L, Wang M, Carr BI. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. J Cell Physiol 2006;208:133-40.
10. Nishikawa Y, Carr BI, Wang M, Kar S, Finn F, Dowd P, et al. Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem 1995;270:28304-10.
11. Tanaka T, Furutama D, Sakai R, Fujita A, Kimura F, Tagami M, et al. Biological roles of anti-GM1 antibodies in patients with Guillain-Barre syndrome for nerve growth factor signaling. Biochim Biophys Acta 2007;1772:543-8.
12. Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt V, Sieverts H, et al. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett 2005;228: 143-53.
13. Woo CW, Lucarelli E, Thiele CJ. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number. Oncogene 2004;23:1522-30.
14. Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM. Multiple defects of the nerve growth factor receptor in human neuroblastomas. Cell Growth Differ 1990;1:421-8.
15. Klein R, Jing SQ, Nanduri V, O'Rourke E, Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991;65:189-97.
16. Sugimoto T, Kuroda H, Horii Y, Moritake H, Tanaka T, Hattori S. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells. Jpn J Cancer Res 2001;92:152-60.
17. Carr BI, Wang Z, Kar S. K vitamins, PTP antagonism, and cell growth arrest. J Cell Physiol 2002;193:263-74.
18. Yamaguchi Y, Tabata K, Asami S, Miyake M, Suzuki T. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma. Biol Pharm Bull 2007;30:638-43.